{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:34:17Z","timestamp":1787506457527,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1097\/mlr.0b013e3181e41bcb","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T07:45:23Z","timestamp":1281599123000},"page":"761-766","source":"Crossref","is-referenced-by-count":50,"title":["Impact of Restricted Reimbursement on the Use of Statins in Finland"],"prefix":"10.1097","volume":"48","author":[{"given":"Jaana E.","family":"Martikainen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena K.","family":"Saastamoinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarit J.","family":"Korhonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Enlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arja","family":"Helin-Salmivaara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210211","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00019053-200321020-00002","article-title":"European healthcare policies for controlling drug expenditure.","volume":"21","author":"Ess","year":"2003","journal-title":"Pharmacoeconomics"},{"key":"R2-2-20210211","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2165\/00019053-200725080-00002","article-title":"Impact of pharmaceutical prior authorisation policies: a systematic review of the literature.","volume":"25","author":"Puig-Junoy","year":"2007","journal-title":"Pharmacoeconomics"},{"key":"R3-2-20210211","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.healthpol.2006.05.001","article-title":"Reference drug programs: effectiveness and policy implications.","volume":"81","author":"Schneeweiss","year":"2007","journal-title":"Health Policy"},{"key":"R5-2-20210211","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1370\/afm.121","article-title":"Changing prescribing patterns and increasing prescription expenditures in Medicaid.","volume":"2","author":"Fink","year":"2004","journal-title":"Ann Fam Med"},{"issue":"suppl 5","key":"R6-2-20210211","first-page":"I27","article-title":"Trends in prescription drug expenditure by Medicaid enrollees.","volume":"44","author":"Banthin","year":"2006","journal-title":"Med Care"},{"key":"R7-2-20210211","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2125.2005.02478.x","article-title":"Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997\u20132003.","volume":"60","author":"Walley","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"R8-2-20210211","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2125.2008.03258.x","article-title":"Shift of statin use towards the elderly in 1995\u20132005: a nation-wide register study in Finland.","volume":"66","author":"Ruokoniemi","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"R9-2-20210211","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.healthpol.2006.04.002","article-title":"Does therapeutic reference pricing always result in cost-containment? The Hungarian evidence.","volume":"80","author":"Kal\u00f3","year":"2007","journal-title":"Health Policy"},{"key":"R10-2-20210211","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10198-009-0172-3","article-title":"The impact of reference pricing on switching behaviour and healthcare utilisation: the case of statins in Germany.","volume":"11","author":"Stargardt","year":"2010","journal-title":"Eur J Health Econ"},{"key":"R12-2-20210211","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1365-2125.2007.02907.x","article-title":"Switching statins in Norway after new reimbursement policy\u2014a nationwide prescription study.","volume":"64","author":"Sakshaug","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"R14-2-20210211","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1586\/14737167.8.4.357","article-title":"Insight into recent reforms and initiatives in Austria: implications for key stakeholders.","volume":"8","author":"Godman","year":"2008","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"R15-2-20210211","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2165\/00019053-200826070-00001","article-title":"Recent national and regional drug reforms in Sweden: implications for pharmaceutical companies in Europe.","volume":"26","author":"Wettermark","year":"2008","journal-title":"Pharmacoeconomics"},{"key":"R17-2-20210211","article-title":"Finnish Statistics on Medicines 2002.","year":"2003"},{"key":"R20-2-20210211","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1365-2125.2008.03345.x","article-title":"Co-medication of statins and CYP3A4 inhibitors before and after introduction of new reimbursement policy.","volume":"67","author":"Devold","year":"2009","journal-title":"Br J Clin Pharmacol"}],"container-title":["Medical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MLR.0b013e3181e41bcb","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:28:42Z","timestamp":1786040922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005650-201009000-00002"}},"subtitle":["A Register-Based Study"],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mlr.0b013e3181e41bcb","relation":{},"ISSN":["0025-7079"],"issn-type":[{"value":"0025-7079","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}